A fundamental discovery reported in the March 1st issue of the journal Nature, uncovers the first molecular evidence linking the body's natural circadian rhythms to sudden cardiac death (SCD). Ventricular arrhythmias, or ...
Feb 22, 2012
0
0
(HealthDay)—Farxiga (dapagliflozin) oral tablets are now approved for adults with chronic kidney disease at risk for disease progression, the U.S. Food and Drug Administration announced Friday.
May 4, 2021
0
9
The anti-inflammatory benefits of a common gout medicine may help save the lives of heart failure patients, researchers say.
May 23, 2022
0
7
Patients who received an implantable heart rhythm monitor after suffering a heart attack did not have fewer subsequent cardiovascular events overall, but a subset of patients whose heart attack was classified as non-ST segment ...
Apr 5, 2022
0
32
Cardiomyopathy is not a uniform disease. Rather, individual genetic defects lead to heart failure in different ways, an international consortium reports in Science.
Aug 4, 2022
0
18
A Rhode Island Hospital researcher has found that the majority of bariatric surgery patients being treated for obesity have clinically significant obstructive sleep apnea (OSA), but report fewer symptoms than other sleep ...
Aug 9, 2012
0
0
The largest medical record-based study ever of adverse events suffered by hospitalized patients in the U.S., published in the July 12 issue of JAMA, reports a significant decrease in the rate of adverse events over the last ...
Jul 12, 2022
0
9
Researchers from the University of Calgary, the Interdisciplinary Chronic Disease Collaboration (ICDC), and social impact creative agency Emergence Creative are announcing dramatic results that demonstrate a significant improvement ...
Mar 6, 2023
0
18
Adaptive servo-ventilation (ASV) therapy increases mortality and should not be used to treat central sleep apnoea in heart failure patients with reduced ejection fraction, the SERVE-HF trial shows.
Sep 1, 2015
0
10
Cardiovascular complications and hypoglycemia (low blood sugar) were common nonfatal complications in adults 60 years of age and older with diabetes, according to a study published by JAMA Internal Medicine.
Dec 9, 2013
0
0
